Ani Pharmaceuticals Inc (ANIP)
R&D to Revenue
5.54%
Quarterly · Period ending:
ANIP R&D to Revenue
Latest reported5.54%period ending
Latest reported5.54%period ending
ANIP Quarterly R&D/Revenue (0.00% → 5.54%)
Latest values, visible window
High-resolution chart · PNG
ANIP r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 5.5431% | |
| 4.4639% | |
| 4.9628% | |
| 5.4009% | |
| 7.8227% | |
| 5.3591% | |
| 8.7347% | |
| 6.8279% | |
| 5.2854% | |
| 7.6483% | |
| 7.4946% | |
| 8.4359% | |
| 6.3271% | |
| 5.5475% | |
| 5.5416% | |
| 9.1349% | |
| 5.6394% | |
| 8.1797% | |
| 5.1535% | |
| 4.7175% | |
| 5.7686% | |
| 5.4438% | |
| 6.433% | |
| 5.5475% | |
| 6.2616% | |
| 12.7456% | |
| 9.7527% | |
| 9.7045% | |
| 10.6205% | |
| 8.2686% | |
| 6.0957% | |
| 9.2046% | |
| 10.8678% | |
| 4.5221% | |
| 5.6063% | |
| 5.4688% | |
| 4.8409% | |
| 4.4174% | |
| 0.3534% | |
| 2.7021% | |
| 2.438% | |
| 4.6996% | |
| 3.6651% | |
| 4.0807% | |
| 5.0984% | |
| 2.1437% | |
| 2.7% | |
| 5.0785% | |
| 12.8028% | |
| 3.4499% | |
| 4.9753% | |
| 5.7923% | |
| 7.1069% | |
| 670.1937% | |
| 123.7357% | |
| 3,508.4533% | |
| 4,962.5896% | |
| 4,546.6816% | |
| 5,859.2386% | |
| 6,291.6081% | |
| 13,723.3473% | |
| 26,077.9298% | |
| 8,323.2668% | |
| 18,928.3104% | |
| 0% | |
| 413.4821% | |
| 351.8461% | |
| 32,131.3096% | |
| 3,033.5924% | |
| 4,489.741% | |
| 106.8064% | |
| 6,474.0816% | |
| 15,207.8472% | |
| 5,873.075% | |
| 368.2279% | |
| 2,616.3177% | |
| 1,940.1564% | |
| 1,805.7461% | |
| 6.8071% | |
| 546.3014% | |
| 635.9952% | |
| 1,203.2228% | |
| 1,046.9398% | |
| 1,508.8318% | |
| 4,228.1998% | |
| 7,503.1524% | |
| 6,181.9394% | |
| 22,769.8012% | |
| 37,494.9558% | |
| 19,908.7343% | |
| -1,775.2172% | |
| 3,780.4835% | |
| 0% | |
| 952.585% | |
| 99.2949% | |
| 137.816% | |
| 0% | |
| 0% | |
| -44.6321% | |
| 41.1547% |